Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
307 studies found for:    (North Carolina) [LOCATION-STATE] AND (prostate cancer) [CONDITION]
Show Display Options
Rank Status Study
1 Completed To Explore Racial Differences in Potential Risk Factors for Developing Prostate Cancer in the VA Population.
Condition: Prostate Cancer
Intervention:
2 Completed Vaccine Therapy in Treating Patients With Metastatic Prostate Cancer
Condition: Prostate Cancer
Intervention: Biological: PSA RNA-pulsed dendritic cell vaccine
3 Terminated Vaccine Therapy in Treating Patients With Metastatic Prostate Cancer
Condition: Prostate Cancer
Intervention: Biological: therapeutic autologous dendritic cells
4 Recruiting Molecular Mechanisms Underlying Prostate Cancer Disparities
Condition: Prostate Cancer
Intervention: Device: Biopsy or prostatectomy
5 Terminated Celecoxib in Treating Patients With Relapsed Prostate Cancer Following Radiation Therapy or Radical Prostatectomy
Condition: Prostate Cancer
Intervention: Drug: celecoxib
6 Completed
Has Results
Vitamin D and Soy Supplements in Treating Patients With Recurrent Prostate Cancer
Condition: Prostate Cancer
Interventions: Dietary Supplement: cholecalciferol;   Dietary Supplement: genistein;   Dietary Supplement: soy isoflavones;   Genetic: polymerase chain reaction;   Genetic: protein expression analysis;   Other: immunologic technique;   Other: laboratory biomarker analysis
7 Completed Docetaxel, Androgen Ablation Therapy, and External-Beam Radiation Therapy in Treating Patients With High-Risk Localized Prostate Cancer
Condition: Prostate Cancer
Interventions: Drug: docetaxel;   Drug: leuprolide acetate;   Radiation: radiation therapy
8 Withdrawn Genistein in Treating Patients With Stage II, Stage III, or Stage IV Prostate Cancer
Condition: Prostate Cancer
Intervention: Dietary Supplement: genistein
9 Completed C-11 Choline PET-CT Scan in Finding Metastases in Patients With Newly Diagnosed High-Risk Prostate Cancer
Condition: Prostate Cancer
Interventions: Procedure: needle biopsy;   Drug: PET-CT scans supplemented with 11C-Choline tracer
10 Active, not recruiting Soy Supplements in Treating Patients Undergoing Surgery for Localized Prostate Cancer
Condition: Prostate Cancer
Interventions: Dietary Supplement: soy isoflavones;   Dietary Supplement: soy protein isolate;   Other: placebo
11 Recruiting Dendreon Lymph Node Biopsy in Metastatic Castrate-Resistant Prostate Cancer
Condition: Prostate Cancer
Interventions: Drug: Sipuleucel-T;   Procedure: Lymph Node Biopsy
12 Completed Coping in African American Prostate Cancer Survivors
Condition: Prostate Cancer
Interventions: Behavioral: Coping Skills Training;   Behavioral: Prostate Cancer Education
13 Terminated Using Walk With Ease Walking Program With Men 65 and Older Being Treated for Prostate Cancer
Condition: Prostate Cancer
Intervention: Behavioral: Walk with Ease
14 Active, not recruiting Stereotactic Body Radiotherapy (SBRT) for Prostate Cancer
Condition: Prostate Cancer
Intervention: Radiation: SBRT Prostate
15 Withdrawn Ciprofloxacin Compared to Placebo in Diagnosing Prostate Cancer in Patients Undergoing Prostate Biopsy
Condition: Prostate Cancer
Interventions: Drug: ciprofloxacin;   Other: placebo;   Other: quality-of-life assessment;   Other: laboratory biomarker analysis
16 Withdrawn Pilot Study of NanoKnife for Ablation of Prostate Cancer in Low Risk Patients
Condition: Prostate Cancer
Intervention: Device: NanoKnife Procedure
17 Recruiting CTC Immune Checkpoint
Condition: Prostate Cancer
Intervention: Device: CTC biomarker expression prevalence
18 Completed Using Serum Parathyroid Hormones and Calcium to Improve Prostate Cancer Diagnosis
Condition: Prostate Cancer
Intervention: Other: This study has no intervention
19 Recruiting Men With Metastatic Castrate-Resistant Prostate Cancer Treated With Either Sipuleucel-T (Provenge®), Abiraterone Acetate (Zytiga®) or Enzalutamide (Xtandi®) Undergoing Cardiopulmonary EXercise Testing
Condition: Prostate Cancer
Interventions: Drug: Enzalutamide;   Drug: Abiraterone acetate;   Drug: Sipuleucel-T
20 Terminated Update and Biodistribution of [F-18]FMDHT pET/CT in Normal Healthy Volunteers and Patients With Metastatic Prostate Cancer - A First in Human Subject Study With [F-18] FMDHT
Condition: Prostate Cancer
Intervention: Drug: [F-18] fluorinated dihydrotestosterone (FDHT)

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.